Key result
A 32-year-old male with sickle cell anemia and moyamoya syndrome dramatically improved following blood transfusions and was discharged on daily aspirin.
Case Report (n=1)
Highlights a rare presentation of moyamoya syndrome in an adult patient with sickle cell disease.
Documents rare adult moyamoya-sickle cell association; extends limited literature but leaves screening and management questions open.
Moyamoya disease (MMD) is an unusual vasculopathy in which the blood vessels of the brain are occluded, resulting in thrombosis. When MMD occurs in association with an underlying pathology, it is known as moyamoya syndrome. The association of moyamoya syndrome with sickle cell disease is uncommon. Herein, we report a case of moyamoya syndrome in a 32-year-old male adult patient.
No takes yet. Share an insight, caveat, or question.
Yamani et al. (2020) conducted a case report in Moyamoya syndrome with sickle cell anemia (n=1). Blood transfusion and aspirin was evaluated on Clinical improvement. A 32-year-old male with sickle cell anemia and moyamoya syndrome dramatically improved following blood transfusions and was discharged on daily aspirin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: